Chloroquine Retinopathy under Inadequately Weight Adjusted Dosage: Early Detection by Multimodal Imaging

P. Arendt; H. Gerding

doi:10.1055/s-0042-121573

Klinische Monatsblätter für Augenheilkunde, Table of Contents

Klin Monbl Augenheilkd 2017; 234(04): 543-545
DOI: 10.1055/s-0042-121573

Der interessante Fall

Georg Thieme Verlag KG Stuttgart · New York

Chloroquine Retinopathy under Inadequately Weight Adjusted Dosage: Early Detection by Multimodal Imaging

Chloroquin-Retinopathie unter inadäquater gewichtsorientierter Dosierung: Früherkennung durch multimodale Bildgebung

P. Arendt

¹Klinik Pallas, Olten, Switzerland (Director: Prof. Dr. Heinrich Gerding)

²Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Switzerland (Director: Prof. Dr. Dr. Sebastian Wolf)

,

H. Gerding

¹Klinik Pallas, Olten, Switzerland (Director: Prof. Dr. Heinrich Gerding)

³Department of Ophthalmology, University of Münster, Münster (Director: Prof. Dr. Nicole Eter)

› Author Affiliations

Abstract

Full Text

References

References
1 Finbloom DS, Silver K, Newsome DA, Gunkel R. Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity. J Rheumatol 1985; 12: 692-694
2 Bernstein HN. Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy. Am J Med 1983; 75: 25-34
3 Chen E, Brown DM, Benz MS. et al. Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the “flying saucer” sign). Clin Ophthalmol 2010; 4: 1151-1158
4 Ascaso FJ, Rodríguez NA, San Miguel R. et al. The “flying saucer” sign on spectral domain optical coherence tomography in chloroquine retinopathy. Arthritis Rheum 2013; 65: 2322
5 Rüther K, Foerster J, Berndt S. et al. Variabilität der retinotoxischen Gesamtdosis Chloroquin/Hydroxychloroquin. Ophthalmologe 2007; 104: 875-880
6 Marmor MF, Kellner U, Melles RB. et al. Recommendations on screening for chloroquin and hydroxychloroquine retinopathy (2016 revison). Ophthalmology 2016; 123: 1386-1394
7 Araiza-Casillas R, Cárdenas F, Morales Y. et al. Factors associated with chloroquine-induced retinopathy in rheumatic diseases. Lupus 2004; 13: 119-124
8 Mavrikakis I, Sfikakis PP, Mavrikakis E. et al. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: A reappraisal. Ophthalmology 2003; 110: 1321-1326
9 Mackenzie AH. Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials. Am J Med 1983; 75: 40-45